Poly(sodium 4-styrene sulfonate): An effective candidate topical antimicrobial for the prevention of sexually transmitted diseases

Journal of Infectious Diseases

Volumn 181, Issue 2, 2000, Pages 770-773

  Herold, Betsy C ^a   Bourne, Nigel ^b   Marcellino, Daniel ^a   Kirkpatrick, Risa ^c   Strauss, Daniel M ^a   Zaneveld, Lourens J D ^d   Waller, Donald P ^e   Anderson, Robert A ^d   Chany, Calvin J ^d   Barham, Beverly J ^c   Stanberry, Lawrence R ^b   Cooper, Morris D ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RUSH MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; POLY(SODIUM 4 STYRENE SULFONATE); SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GENITAL HERPES; HERPES SIMPLEX VIRUS; MOUSE; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CELLS, CULTURED; CERVIX UTERI; CHLAMYDIA TRACHOMATIS; FEMALE; HELA CELLS; HEPARIN; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MICE; NEISSERIA GONORRHOEAE; POLYSTYRENES; SEXUALLY TRANSMITTED DISEASES;

EID: 0034090829     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315228     Document Type: Article

References (15)

1. Louv WC, Austin H, Alexander WJ, Stagno S, Cheeks J. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis 1988; 158:518-23.
2. Whaley KJ. Nonoxynol-9 protects mice against vaginal transmission of genital herpes infections. J Infect Dis 1993; 168:1009-11.
3. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL. A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998; 339:504-10.
4. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS 1993; 4:165-70.
5. Foldesy RG, Homm RE, Levinson SL, Hand DW. Multiple actions of a novel vaginal contraceptive compound, ORF 13904. Fertil Steril 1986; 45:550-4.
6. Homm RE, Foldesy RG, Hand DW. ORF 13904, a new long-acting vaginal contraceptive. Contraception 1985; 32:267-75.
7. Zeitlin L, Whaley KJ, Hegarty TA, Moench TR, Cone RA. Tests of vaginal microbicides in the mouse genital herpes model. Contraception 1997; 56:329-35.
8. Herold BC, Siston A, Bremer J, et al. Sulfated carbohydrate compounds prevent microbial adherence by sexually transmitted disease pathogens. Antimicrob Agents Chemother 1997; 41:2776-80.
9. Herold BC, Kirkpatrick R, Marcellino D, et al. Bile salts: natural detergents for the prevention of sexually transmitted diseases. Antimicrob Agents Chemother 1999; 43:745-51.
10. Stanberry LR, Bernstein DI, Burke RL, Pachl C, Myers MG. Recombinant herpes simplex virus glycoprotein protects against initial and recurrent genital herpes. J Infect Dis 1987; 155:914-20.
11. Fahey JV, Humphrey SL, Stern JE, Wira CR. Secretory component production by polarized epithelial cells from the human female reproductive tract. Immunol Invest 1998; 27:167-80.
12. Herold BC, Gerber SI, Belval BJ, Siston AM, Shulman N. Differences in the susceptibility of herpes simplex virus types I and 2 to modified heparin compounds suggest serotype differences in viral entry. J Virol 1996; 70:3461-9.
13. Bourne N, Milligan GN, Schleiss MR, Bernstein DI, Stanberry LR. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2. Vaccine 1996; 14:1230-4.
14. Spear PG, Shieh MT, Herold BC, WuDunn D, Koshy TI. Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv Exp Med Biol 1992; 313:341-53.
15. Wald A, Matson P, Ryncarz A, Corey L. Detection of herpes simplex virus DNA in semen of men with genital HSV-2 infection. Sex Transm Dis 1999; 26:1-3.